Table 2.

The effects of interventions on tested parameters after 4 weeks in study patients. The values are presented as mean ± SD.

Parameter (unit)	Vaccinium  (n = 25)	Placebo  (n = 25)	P-value
BMI (kg/m2)
Baseline	25.40 ± 1.75	25.21 ± 2.01	0.062
End	25.06 ± 1.60	25.31 ± 2.07
Change	−0.33 ± 0.45	0.10 ± 0.45
Total cholesterol (mg/dL)
Baseline	226.48 ± 32.09	220.20 ± 45.76	<0.001
End	192.04 ± 28.81	223.52 ± 42.31
Change	−34.44 ± 22.44	3.32 ± 15.47
LDL-C (mg/dL)
Baseline	132.80 ± 23.76	121.08 ± 32.06	0.004
End	121.36 ± 27.46	124.36 ± 30.29
Change	−11.44 ± 3.28	3.28 ± 16.04
TG (mg/dL)
Baseline	226.20 ± 96.99	191.36 ± 56.54	<0.001
End	156.56 ± 46.76	198.56 ± 63.30
Change	−69.64 ± 76.86	7.20 ± 27.51
HDL-C (mg/dL)
Baseline	45.76 ± 9.73	46.56 ± 10.52	0.631
End	45.60 ± 9.72	45.68 ± 9.72
Change	−0.16 ± 6.36	−0.88 ± 3.85
hs-CRP (mg/L)
Baseline	2.53 ± 2.33	2.80 ± 2.35	0.190
End	1.99 ± 1.60	3.04 ± 2.34
Change	−0.54 ± 2.83	0.23 ± 0.49
MDA (µmol/L)
Baseline	0.738 ± 0.266	0.707 ± 0.212	0.013
End	0.648 ± 0.16	0.769 ± 0.26
Change	−0.09 ± 0.23	0.06 ± 0.18